260 results on '"Fu, Edouard L."'
Search Results
2. Evaluation of the introduction of novel potassium binders in routine care; the Stockholm CREAtinine measurements (SCREAM) project
3. Adherence and persistence to novel glucose-lowering medications in persons with type 2 diabetes mellitus undergoing routine care
4. Novel glucose-lowering drugs and the risk of acute kidney injury in routine care; the Stockholm CREAtinine Measurements (SCREAM) project
5. A population-based cohort defined risk of hyperkalemia after initiating SGLT-2 inhibitors, GLP1 receptor agonists or DPP-4 inhibitors to patients with chronic kidney disease and type 2 diabetes
6. Comparative Safety and Effectiveness of Warfarin or Rivaroxaban Versus Apixaban in Patients With Advanced CKD and Atrial Fibrillation: Nationwide US Cohort Study
7. Long-term Visit-to-Visit Variability in Hemoglobin A1c and Kidney-Related Outcomes in Persons With Diabetes
8. A nationwide cohort study comparing the effectiveness of diuretics and calcium channel blockers on top of renin-angiotensin system inhibitors on chronic kidney disease progression and mortality
9. Authorsʼ Reply: Integer Cystatin C Values: Impact on Discordance Group Assignment and Accuracy of GFR-Estimating Equations
10. Cardiorenal Outcomes Among Patients With Atrial Fibrillation Treated With Oral Anticoagulants
11. Risk of Acute Kidney Injury Among Older Adults With Heart Failure and With Reduced Ejection Fraction Treated With Angiotensin-Neprilysin Inhibitor vs Renin-Angiotensin System Inhibitor in Routine Clinical Care
12. Discordances Between Creatinine and Cystatin C–Based Estimated GFR and Adverse Clinical Outcomes in Routine Clinical Practice
13. Defining measures of kidney function in observational studies using routine health care data: methodological and reporting considerations
14. Association between cholinesterase inhibitors and kidney function decline in patients with Alzheimer’s dementia
15. Target Trial Emulation to Improve Causal Inference from Observational Data: What, Why, and How?
16. Accuracy of GFR Estimating Equations in Patients with Discordances between Creatinine and Cystatin C-Based Estimations
17. #1737 Kidney function, kidney function decline, and the risk of abdominal aortic aneurysm: the Stockholm CREAtinine Measurements (SCREAM) project
18. #2888 Measured glomerular filtration rate and risk of adverse outcomes in 6059 patients from the Stockholm CREAtinine Measurements (SCREAM) project
19. #762 Hyperkalemia and discontinuation of RAS blockade after initiating SGLT-2i vs. DPP-4i in patients with type 2 diabetes; a population-based cohort study
20. #2576 Effect of dialysis versus conservative care on all-cause mortality in older patients with advanced CKD: nationwide Swedish cohort study
21. WCN24-255 Evaluation of the introduction of novel potassium binders in routine care; the Stockholm CREAtinine Measurements (SCREAM) project
22. Safety of Sodium-Glucose Cotransporter-2 Inhibitors in Patients with CKD and Type 2 Diabetes: Population-Based US Cohort Study
23. Comparative effectiveness of SGLT2i versus GLP1-RA on cardiovascular outcomes in routine clinical practice
24. Patient-Reported Measures and Lifestyle Are Associated With Deterioration in Nutritional Status in CKD Stage 4-5: The EQUAL Cohort Study
25. Kidney Function, Kidney Replacement Therapy, and Mortality in Men and Women
26. GLP-1 receptor agonist versus DPP-4 inhibitor and kidney and cardiovascular outcomes in clinical practice in type-2 diabetes
27. Stopping renin-angiotensin system inhibitors after hyperkalemia and risk of adverse outcomes
28. Decoy receptors as biomarkers for exploring aetiology and designing new therapies.
29. eGFR slope as a primary endpoint for clinical trials of CKD progression: one size fits all?
30. Abstract 11127: Effectiveness of Sodium-Glucose Cotransporter-2 Inhibitors in Patients With Heart Failure With Preserved Ejection Fraction and Type 2 Diabetes
31. SGLT-2 inhibitors, GLP-1 receptor agonists, and DPP-4 inhibitors and risk of hyperkalemia among people with type 2 diabetes in clinical practice: population based cohort study.
32. Accuracy of GFR estimating equations based on creatinine, cystatin C or both in routine care.
33. Accuracy of GFR estimating equations based on creatinine, cystatin C or both in routine care
34. Comparative Safety and Effectiveness of Warfarin or Rivaroxaban Versus Apixaban in Patients With Advanced CKD and Atrial Fibrillation: Nationwide US Cohort Study
35. Practice variation in the treatment of patients with renal hyperparathyroidism: a survey-based study in the Netherlands
36. Association of Low Glomerular Filtration Rate With Adverse Outcomes at Older Age in a Large Population With Routinely Measured Cystatin C.
37. Routine care data and the benefits of GLP1 receptor agonists on slowing kidney function decline
38. The long-term benefits of early intensive therapy in chronic diseases—the legacy effect
39. Absolute and Relative Risks of Kidney Outcomes Associated With Lithium vs Valproate Use in Sweden
40. Sodium–glucose cotransporter 2 inhibitors vs. sitagliptin in heart failure and type 2 diabetes: an observational cohort study
41. #4126 LONG-TERM VISIT TO VISIT VARIABILITY IN HBA1C AND KIDNEY RELATED OUTCOMES IN PERSONS WITH DIABETES
42. Association Between β-Blocker Use and Mortality/Morbidity in Patients With Heart Failure With Reduced, Midrange, and Preserved Ejection Fraction and Advanced Chronic Kidney Disease
43. Stopping renin-angiotensin system blockers after acute kidney injury and risk of adverse outcomes: parallel population-based cohort studies in English and Swedish routine care
44. Estimating the prevalence of chronic kidney disease while accounting for nonrandom testing with inverse probability weighting
45. Finerenone in chronic kidney disease and type 2 diabetes: the known and the unknown
46. Novel glucose-lowering drugs and the risk of acute kidney injury in routine care; the Stockholm CREAtinine Measurements (SCREAM) project
47. Pharmacologic Treatment of Type 2 Diabetes in the United States, Sweden, and Israel
48. Pharmacologic Treatment of Type 2 Diabetes in the U.S., Sweden, and Israel
49. Sex Differences in the Recognition, Monitoring, and Management of CKD in Health Care: An Observational Cohort Study
50. Use of guideline‐recommended medical therapy in patients with heart failure and chronic kidney disease: from physician's prescriptions to patient's dispensations, medication adherence and persistence
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.